LATE-NC与神经病理病变及认知能力的关联:一项基于人群的尸检研究
该研究基于巴西圣保罗大学老龄化研究生物样本库2004至2024年的尸检数据,纳入1860名参与者,分析LATE-NC与认知表现及共病神经病理病变的关联。结果显示LATE-NC患病率为7.4%,且与海马硬化、晚期Braak NFT分期、路易体病理及CDR-SOB评分独立相关,其认知关联程度与中/重度ADNC相似。
要点
- LATE-NC在多样性样本中患病率为7.4%,期2-3与海马硬化强关联(OR=14.95)。
- LATE-NC与CDR-SOB评分独立关联(β=4.06),程度与中/重度ADNC(β=3.78)相似。
- LATE-NC还与晚期Braak NFT分期(OR=2.23)和路易体病理(OR=1.89)相关。
核心结论
- 在民族和 socioeconomic 多样化的巴西尸检样本中,LATE-NC患病率为7.4%,且与认知损害独立相关,其关联程度与中/重度ADNC相似。
研究设计与样本
- 横断面研究,分析巴西老龄化研究生物样本库2004至2024年的连续尸检数据,纳入1860名≥18岁且有知情者的参与者。
主要发现
- LATE-NC总体患病率为7.4%(期1:3.0%;期2:4.0%;期3:0.4%)。
- 调整社会人口学、临床和其他神经病理协变量后,LATE-NC(期2-3)与海马硬化(OR=14.95;95%CI 7.42-30.27;p<0.001)相关。
- LATE-NC(期2-3)与晚期Braak NFT分期(OR=2.23;95%CI 1.32-3.83;p=0.003)和路易体病理(OR=1.89;95%CI 1.02-3.37;p=0.036)相关。
- 控制其他病理后,LATE-NC与CDR-SOB评分相关(β=4.06;95%CI 2.95-5.18;p<0.001),与中/重度ADNC的关联(β=3.78;95%CI 3.14-4.42;p<0.001)相似。
临床怎么用
- 在认知障碍评估中,尤其是伴有海马硬化或路易体病理时,应考虑LATE-NC作为潜在贡献因素。
局限性
- 横断面设计限制因果推断。
- 部分估计值因晚期病例数少而置信区间宽。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is a common finding in aging brains. However, most previous studies were limited to ethnoracially homogeneous cohorts from high-income countries. The objective of this study was to investigate the associations between LATE-NC, cognitive performance, and coexisting neuropathologic lesions in a large, ethnoracially and socioeconomically diverse sample from Brazil. METHODS: This cross-sectional study analyzed data from the Biobank for Aging Studies, a Brazilian population-based autopsy study based at the University of São Paulo. The study included a consecutive series of autopsies performed between 2004 and 2024. Inclusion criteria required participants to be at least 18 years old with a knowledgeable informant. LATE-NC, Alzheimer disease neuropathologic change (ADNC), Lewy body pathology (LBP), lacunar infarcts, small vessel disease, cerebral amyloid angiopathy, and hippocampal sclerosis were assessed following international criteria. Cognitive abilities were evaluated with the Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB). Logistic and linear regression models were applied to examine associations of LATE-NC with comorbid neuropathologies and cognitive outcomes, with adjustments for sociodemographic, clinical, and neuropathologic covariates. RESULTS: The sample comprised 1,860 participants (mean age = 72.6 ± 14.2 years; 49.1% female; 62.2% White; 35.4% Black). LATE-NC was present in 7.4% of participants (stage 1: 3.0%; stage 2: 4.0%; stage 3: 0.4%). After adjustment for sociodemographic, clinical, and other neuropathologic covariates, LATE-NC (stages 2-3) was associated with hippocampal sclerosis (OR = 14.95; 95% CI 7.42-30.27; p < 0.001), advanced Braak NFT stages (OR = 2.23; 95% CI 1.32-3.83; p = 0.003), and LBP (OR = 1.89; 95% CI 1.02-3.37; p = 0.036). Factoring in other pathologies, LATE-NC was associated with the CDR-SOB score (β = 4.06; 95% CI 2.95-5.18; p < 0.001), demonstrating a consistent association with cognition, similar to the one observed for moderate/severe ADNC (β = 3.78; 95% CI 3.14-4.42; p < 0.001) in the same sample. DISCUSSION: LATE-NC was prevalent and associated with cognitive impairment in this ethnoracially and socioeconomically diverse sample. The cross-sectional design limits causal inference, and some estimates had wide confidence intervals due to the small number of advanced-stage cases.
引用
- Matos Silva C, Justo AFO, Ribeiro Paes V, et al. Association of LATE-NC With Neuropathologic Lesions and Cognitive Abilities: A Population-Based Autopsy Study. Neurology. 2026. PMID: 42987245. doi:10.1212/WNL.0000000000218694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。